Table 2.
The relationship between general information and postoperative complications.
| Variable | Postoperative complications (n, %) | P | |
|---|---|---|---|
| Present, n = 33 | Absent, n = 77 | ||
| Sex (n, %) | |||
| Male | 28 (84.8) | 49 (63.6) | 0.026* |
| Female | 5 (15.2) | 28 (36.4) | |
| Age (years), median (IQR) | 54 (45.5–62) | 56 (46–62.5) | 0.829 |
| Underlying medical conditions (n, %) | |||
| Tuberculosis (n, %) | 13 (39.4) | 33 (42.9) | 0.736 |
| Diabetes (n, %) | 3 (9.1) | 14 (18.2) | 0.375 |
| Hypertension (n, %) | 2 (6.1) | 18 (23.4) | 0.059 |
| SLE (n, %) | 0 | 1 (1.3) | 1.000 |
| Clinical symptoms > 6 months (n, %) | |||
| Yes | 22 (66.7) | 58 (75.3) | 0.350 |
| No | 11 (33.3) | 19 (24.7) | |
| Hemoptysis (n, %) | |||
| Yes | 19 (57.6) | 44 (57.1) | 0.966 |
| No | 14 (42.4) | 33 (42.9) | |
| Site of the disease (n, %) | |||
| Left | 13 (39.4) | 29 (37.7) | 0.282 |
| Right | 20 (60.6) | 48 (62.3) | |
| Duration of voriconazole antifungal medication before surgery (days), median (IQR) | 30 (14–46) | 30 (21–50) | 0.211 |
| Preoperative BAE (n, %) | |||
| Yes | 4 (12.1) | 8 (10.4) | 1.000 |
| No | 29 (87.9) | 69 (89.6) | |
| BMI (kg/m2), median (IQR) | 22.8 (22.1–24.1) | 22.6 (21.6–23.5) | 0.202 |
| FEV1 (L) (IQR) | 2.45 (2.36–2.66) | 2.65 (2.35–3.12) | 0.063 |
| FVC (L) (IQR) | 3.62 (3.29–3.71) | 2.45 (2.36–2.67) | 0.514 |
| Maximum diameter of lesion (cm) (IQR) | 8 (6.5–10) | 8 (6–10) | 0.809 |
| Degree of adhesion on CT (n, %) | |||
| No or mild adhesion | 4 (12.1) | 22 (28.6) | 0.118 |
| Moderate adhesion | 19 (57.6) | 41 (53.2) | |
| Severe adhesion | 10 (30.3) | 14 (18.2) | |
| Operative approach (n, %) | |||
| OS group, n = 59 | 24 (72.8) | 35 (45.5) | 0.009* |
| Uni-VATS group, n = 51 | 9 (27.2) | 42 (54.5) | |
| Surgical resection method (n, %) | |||
| Subsegmentectomy | 6 (18.2) | 15 (19.5) | 1.000 |
| Lobectomy | 27 (81.8) | 62 (80.5) | |
SLE systemic lupus erythematosus.
*The difference was statistically significant.